MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Question-Order Effect Experiment to Measure HIV Stigma
Not Applicable
Completed
- Conditions
- HIV
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06969690
- Locations
- 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda
Personalized Normative Feedback to Increase HIV Testing
Not Applicable
Completed
- Conditions
- HIV StigmaHIV Testing
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 1300
- Registration Number
- NCT06969677
- Locations
- 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda
Resiliency Intervention for Patients With ALS and Their Care-Partners
Not Applicable
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)Emotional Distress
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06968468
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
Not Applicable
Not yet recruiting
- Conditions
- Suicide AttemptSuicide Ideation
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06967545
Peer Recovery Coaching for Tobacco Abstinence in People With Opioid Use Disorder
Not Applicable
Not yet recruiting
- Conditions
- Peer Recovery Coaching for TUD
- Interventions
- Drug: Dual NRTBehavioral: PeerTTS
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06965153
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
Early Phase 1
Not yet recruiting
- Conditions
- Carotid Artery DiseasesPeripheral Arterial Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-05-05
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT06957821
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
TMS for Cognitive Decline in Aging and Preclinical AD
Not Applicable
Recruiting
- Conditions
- Prodromal Alzheimer's DiseasePreclinical Alzheimer's DiseaseHealthy AgingCognitive Decline
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06956300
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
iNO300 Therapy in Critically Ill Patients With Pneumonia
Early Phase 1
Not yet recruiting
- Conditions
- Critical IllnessPneumonia
- Interventions
- Drug: High dose inhaled nitric oxideOther: Sham treatmentOther: standard therapy
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT06950294
Omalizumab Weight-Based Dosing Efficacy Trial
Phase 2
Recruiting
- Conditions
- AllergiesFood Allergy
- Interventions
- Drug: 5mg/kg omalizumab injectionDrug: 15mg/kg omalizumab injection
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06943534
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸University of Texas Southwestern, Dallas, Texas, United States
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
Phase 1
Not yet recruiting
- Conditions
- Neurofibromatosis 1 (NF1)Neurofibromatosis Type I
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06934928
- Locations
- 🇺🇸
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, United States